6th Sep 2021 12:39
Omega Diagnostics Group PLC - medical diagnostics company - Says all of the supporting data and documentation relating to its submission for CE marking for self-test use for the Visitect Covid-19 antigen test have been filed. The submission process has been running in parallel with the usability study conducted by Ulster University since mid-July and the conclusion of the Ulster study was the final step in this process. The test is already CE marked for professional-use and once approved would allow the test to be sold in Europe for home-use as well.
Current stock price: 53.56 pence
Year-to-date change: down 17%
By Evelina Grecenko; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
ODX.L